Using patient data for research and analytics: HIPAA and Common Rule routes compared
| Route | Rule | Applies to | What data | Main condition | Who decides or approves | Limits and duties that follow |
|---|---|---|---|---|---|---|
| De-identification by removing identifiers (safe harbor)1 | Rule45 CFR 164.514(b)(2)1 | Applies toHIPAA covered entities1 | What dataHealth information with 18 listed kinds of identifiers removed, for the individual and for relatives, employers or household members; the first three zip code digits may stay where that area holds more than 20,000 people, and ages over 89 may be aggregated into a single category of age 90 or older1 | Main conditionThe covered entity has no actual knowledge that the information could be used, alone or with other information, to identify an individual who is a subject of it1 | Who decides or approvesThe covered entity1 | Limits and duties that followInformation that meets the standard is not individually identifiable health information. The covered entity may assign a re-identification code only if the code is not derived from or related to information about the individual and cannot be translated to identify the individual, and the covered entity does not use or disclose it for any other purpose or disclose the re-identification mechanism (164.514(c))1 |
| De-identification by expert determination1 | Rule45 CFR 164.514(b)(1)1 | Applies toHIPAA covered entities1 | What dataHealth information that an expert finds carries a very small risk of identification1 | Main conditionA person with appropriate knowledge of and experience with generally accepted statistical and scientific methods determines that the risk is very small that the information could be used, alone or with other reasonably available information, by an anticipated recipient to identify an individual1 | Who decides or approvesThe expert, who must document the methods and results of the analysis that justify the determination1 | Limits and duties that followInformation that meets the standard is not individually identifiable health information. The covered entity may assign a re-identification code only if the code is not derived from or related to information about the individual and cannot be translated to identify the individual, and the covered entity does not use or disclose it for any other purpose or disclose the re-identification mechanism (164.514(c))1 |
| Limited data set under a data use agreement1 | Rule45 CFR 164.514(e)1 | Applies toHIPAA covered entities1 | What dataProtected health information without 16 listed direct identifiers; town or city, State and zip code may remain1 | Main conditionUsed or disclosed only for research, public health or health care operations, and only under a data use agreement with the recipient1 | Who decides or approvesThe covered entity, through a data use agreement with the recipient that establishes the permitted uses and disclosures and who may use or receive the data1 | Limits and duties that followThe recipient may not use or further disclose the data beyond the agreement or as required by law, must use appropriate safeguards, report uses or disclosures the agreement does not allow, bind its agents to the same terms, and may not identify the information or contact the individuals1 |
| The individual's authorization for research2 | Rule45 CFR 164.5082 | Applies toHIPAA covered entities2 | What dataThe protected health information the authorization describes in a specific and meaningful way2 | Main conditionA signed and dated authorization with the core elements; for research, including a research database or repository, the expiration may read "end of the research study", "none" or similar language2 | Who decides or approvesThe individual or a personal representative, whose authority must be described2 | Limits and duties that followA research authorization may be combined with any other written permission for the same or another research study, including a consent to participate in research2 |
| Waiver or alteration of authorization by an IRB or privacy board3 | Rule45 CFR 164.512(i)(1)(i) and (i)(2)3 | Applies toHIPAA covered entities3 | What dataThe protected health information the board found necessary, described briefly in its documentation3 | Main conditionNo more than minimal risk to privacy (an adequate plan to protect identifiers, a plan to destroy them at the earliest opportunity unless retention is justified or required, and written assurances against reuse), and the research could not practicably be done without the waiver or without the information3 | Who decides or approvesAn IRB, or a privacy board that includes at least one member not affiliated with the covered entity or the research; the documentation is signed by the chair or a designated member3 | Limits and duties that followWritten assurances that the information will not be reused or disclosed to others, except as required by law, for authorized oversight of the study, or for other research the Privacy Rule permits3 |
| Reviews preparatory to research3 | Rule45 CFR 164.512(i)(1)(ii)3 | Applies toHIPAA covered entities3 | What dataProtected health information needed to prepare a research protocol or for similar purposes preparatory to research3 | Main conditionThe researcher represents that the use or disclosure is sought solely for that purpose and that the information is necessary for the research3 | Who decides or approvesThe covered entity, on the researcher's representations3 | Limits and duties that followNo protected health information is removed from the covered entity by the researcher during the review3 |
| Research on decedents' information3 | Rule45 CFR 164.512(i)(1)(iii)3 | Applies toHIPAA covered entities3 | What dataProtected health information of decedents3 | Main conditionThe researcher represents that the use or disclosure is solely for research on decedents' information and is necessary, and documents the deaths if the covered entity asks3 | Who decides or approvesThe covered entity, on the researcher's representations and any documentation it requests3 | Limits and duties that followThe paragraph sets no conditions beyond the representations and documentation of death3 |
| Common Rule exemption for secondary research on HIPAA-regulated information4 | Rule45 CFR 46.104(d)(4)(iii)4 | Applies toHuman subjects research conducted, supported or otherwise subject to regulation by a Federal department or agency that makes the Common Rule applicable to it5 | What dataIdentifiable health information whose use by the investigator is regulated under 45 CFR parts 160 and 164, subparts A and E4 | Main conditionThe research involves only information collection and analysis for "health care operations" or "research" as defined at 45 CFR 164.501, or for public health activities and purposes under 45 CFR 164.512(b)4 | Who decides or approvesNo consent is required: 46.104(d)(4) covers "secondary research for which consent is not required"4 | Limits and duties that followThe research may involve only information collection and analysis, and the investigator's use of the identifiable health information must be regulated under 45 CFR parts 160 and 164, subparts A and E, for those purposes4 |
| Common Rule exemption for secondary research recorded without identifiers4 | Rule45 CFR 46.104(d)(4)(ii)4 | Applies toHuman subjects research conducted, supported or otherwise subject to regulation by a Federal department or agency that makes the Common Rule applicable to it5 | What dataIdentifiable private information or identifiable biospecimens, recorded so that the identity of subjects cannot readily be ascertained directly or through linked identifiers4 | Main conditionThe investigator does not contact the subjects and will not re-identify them4 | Who decides or approvesNo consent is required under this exemption category4 | Limits and duties that followNo contact with and no re-identification of subjects4 |
| Broad consent for storage and secondary research use4 | Rule45 CFR 46.104(d)(8) and 46.116(d)4 | Applies toHuman subjects research conducted, supported or otherwise subject to regulation by a Federal department or agency that makes the Common Rule applicable to it5 | What dataIdentifiable private information or identifiable biospecimens for secondary research use4 | Main conditionBroad consent obtained under 46.116, documentation of consent or a waiver of documentation under 46.117, a limited IRB review, and no plan to return individual research results to subjects4 | Who decides or approvesThe subject or legally authorized representative gives broad consent; an IRB does a limited review and confirms the research is within its scope4 | Limits and duties that followThe broad consent must describe the types of research that may be done, the information or biospecimens that might be used and whether they may be shared, and how long they may be stored and maintained6 |
| IRB waiver or alteration of informed consent6 | Rule45 CFR 46.116(f)6 | Applies toHuman subjects research conducted, supported or otherwise subject to regulation by a Federal department or agency that makes the Common Rule applicable to it5 | What dataResearch under the Common Rule, including research using identifiable private information or identifiable biospecimens6 | Main conditionThe IRB finds and documents no more than minimal risk, that the research could not practicably be carried out without the waiver or, where relevant, without identifiable information or biospecimens, and that the waiver will not adversely affect rights and welfare6 | Who decides or approvesThe IRB6 | Limits and duties that followAn IRB cannot waive consent for storage, maintenance or secondary research use of identifiable information or biospecimens when the person was asked for broad consent and refused6 |
License: CC BY 4.0. Underlying government texts are public domain or under their own terms. Attribute "Moraph Insights" with a link to the page.
Method
The HIPAA Privacy Rule sections (45 CFR 164.508, 164.512(i), 164.514) and the HHS Common Rule sections (45 CFR 46.101, 46.104, 46.116) were read in the eCFR text up to date as of 2026-11-12 (versioner API) on 2026-11-14, and cells were copied or closely paraphrased from them. Each row is one route the rule text sets out; only the main conditions are shown, and the full lists of identifiers and waiver criteria are in the sources. Other agencies' versions of the Common Rule, FDA human subject rules (21 CFR parts 50 and 56), 42 CFR part 2 and state laws were not compared. This page explains rule text and is not legal advice.
Notes
- Substance use disorder records under 42 CFR part 2 are compared with HIPAA in the part-2-vs-hipaa table.
Sources
- U.S. Department of Health and Human Services. 45 CFR 164.514, Other requirements relating to uses and disclosures of protected health information (de-identification, re-identification, limited data set). Checked .
- U.S. Department of Health and Human Services. 45 CFR 164.508, Uses and disclosures for which an authorization is required. Checked .
- U.S. Department of Health and Human Services. 45 CFR 164.512(i), Uses and disclosures for research purposes. Checked .
- U.S. Department of Health and Human Services. 45 CFR 46.104, Exempt research (Common Rule). Checked .
- U.S. Department of Health and Human Services. 45 CFR 46.101, To what does this policy apply? (Common Rule). Checked .
- U.S. Department of Health and Human Services. 45 CFR 46.116, General requirements for informed consent (Common Rule). Checked .
How we source and check every fact: Editorial standards · Corrections
Last reviewed .
Spotted an error? Tell us and we will check it and correct the table where needed.